We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
93 hedge funds and large institutions have $102M invested in Atossa Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more call options, than puts
Call options by funds: $35M | Put options by funds: $15.6M
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
8% more funds holding
Funds holding: 86 → 93 (+7)
8% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 26
0.34% less ownership
Funds ownership: 1.97% → 1.64% (-0.34%)
55% less capital invested
Capital invested by funds: $225M → $102M (-$123M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
93
Holders Change
+7
Holders Change %
+8.14%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
28
Reduced
26
Closed
13
Calls
$35M
Puts
$15.6M
Net Calls
+$19.5M
Net Calls Change
+$7.32M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.02M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.96M |
| 3 |
D.E. Shaw & Co
New York
|
+$3.48M |
| 4 |
BlackRock
New York
|
+$2.31M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.93M |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9.09M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$7.04M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$6.38M |
| 4 |
Millennium Management
New York
|
-$5.44M |
| 5 |
Jane Street
New York
|
-$4.28M |
